NYSE: UNH
UnitedHealth Group (NYSE: UNH) is a diversified health care and well-being company operating through two complementary businesses. UnitedHealthcare provides health care benefits to approximately 48.5 million consumers across commercial employer and individual plans, Medicare Advantage, Medicare Supplement, Medicaid, and related government programs. Optum serves over 120 million consumers through three divisions: Optum Health delivers integrated value-based care and clinical services; Optum Insight provides technology, analytics, and AI-enabled solutions including autonomous coding and digital prior authorization tools to payers, providers, and life sciences companies; and Optum Rx offers pharmacy care services including a transparent fee-based pharmacy benefit model, specialty pharmacy, and drug cost management. The company is actively advancing reforms around prior authorization simplification, pharmacy transparency, rural hospital support, and affordability initiatives across its businesses. Updated
On October 4, Suze Orman, the personal finance author and former CNBC host, had a warning for her podcast listeners covered by UnitedHealth Group (NYSE:UNH | UNH Price Prediction): “If you have…
A recent pullback and a fresh dividend payout make October an unusual entry point for one overlooked ETF, but the real case for investing $100 a month here has nothing to do…
Her surgeon is scheduled, her prior authorization is approved, and her surgery date is locked in for January. What her insurer has not told her could unravel all three.
Gerelyn Terzo UnitedHealth shareholders spent five years waiting for a stock that barely budged, yet something inside the company kept growing the whole time. Whether that something is enough to make UNH worth holding…
A retired man collects Social Security and a pension, adds $1,000 a month from a popular Treasury fund, and ends up handing the IRS a bill he never needed to pay. The…
UnitedHealthcare's October prior authorization cuts generated headlines about 1,700 procedures, but Medicare Advantage members searching for their scheduled procedure on that list are finding a very different number staring back at them.
Gerelyn Terzo One number buried inside a popular Dow ETF quietly hands a smaller company more of your retirement dollars than a corporate giant worth more than ten times as much, and the reason…
A fresh analyst upgrade is sending Humana (NYSE:HUM | HUM Price Prediction) shares sharply higher, and the rally stands apart from a quiet managed care group. Humana stock is up 7% to…
Three companies with nothing in common all sent dividend checks on the same September day, but only one of them handed shareholders a freshly raised rate. Which one broke from the pack,…
Most beginners chase the highest yield they can find and end up owning a ticking time bomb. One fund built around a completely different logic has quietly turned $2,000 starting positions into…
A 15-year scorecard just revealed how badly active dividend fund managers fared against a passive benchmark, and the results raise a pointed question about whether the most popular dividend ETF belongs in…
A static dividend yield quietly loses ground every month inflation climbs, but five companies have been raising their payouts fast enough to fight back. The question is which ones have the cash…
TPG just bought into the exact Optum clinics that derailed UnitedHealth's profits, and management is hours away from reaffirming guidance that could either validate the deal or reopen a wound investors hoped…
While Wall Street piles into AI darlings, Michael Burry is quietly loading up on call options in three stocks the market left for dead, and his biggest bets carry a very specific…
Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a…
UnitedHealth Group (NYSE: UNH) is a diversified health care and well-being company operating through two complementary businesses.
24/7 Wall St.'s 12-month price target for UNH is $527.25, rated Buy. The Wall Street consensus target is $481.72. UNH price prediction →
